case_images: PMC10757659_01
case_images: Time in range results from intermittent scanning and continuous glucose monitoring after the start of the CFTR modulator therapy (left bar) and after adoption of a low glycaemic index (GI) diet (right bar). The CGM data are summarized as the average of the previous 14 days and categorized as time-in-range based on consensus recommendations. Note that the time spent in "low" and "very low" decreased with the low GI diet, in favour of increase time "in range."
case_images: CRIE2023-9769119.001.jpg
case_images: PMC10757659_01_CRIE2023-9769119.001.jpg
case_images: fig1
case_images: An intermittently scanning continuous glucose monitor showed frequent occurrence of postprandial reactive hypoglycaemia with 20% of the time spent in "low" (54-69 mg/dl) and 4% in "very low" glycaemic range (<54 mg/dl) (Figure 1). This clinical improvement was reflected in the continuous glucose monitor reading, showing a clear reduction in time spent in "low" (5% of time) and "very low" glycaemic range (0% of time) (Figure 1 panel B).